Atom Grants
Discover

    NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)

    Grant supports translation of basic research into clinical tools improving human health by encouraging collaboration between scientists and clinicians for communication disorder research.

    Overview
    Eligibility
    Sources (3)
    Similar Grants
    Researchers

    Funder: National Institutes of Health

    Due Dates: February 13, 2025 (New/Renewal/Resubmission/Revision) | October 13, 2025 (New/Renewal/Resubmission/Revision) | June 12, 2026 (New/Renewal/Resubmission/Revision) | February 12, 2027 (New/Renewal/Resubmission/Revision) | October 12, 2027 (New/Renewal/Resubmission/Revision)

    Funding Amounts: Up to $500,000 direct costs per year (max 5 years); prior approval required for requests ≥$500,000/year; 2–3 awards anticipated per cycle.

    Summary: Supports milestone-driven translational research to convert published basic findings into clinical tools for diagnosis, treatment, or prevention of communication disorders.

    Key Information: Milestone plan required; not for basic discovery, proof-of-concept, or high-risk clinical trials; strong basic-clinical collaboration expected.


    Description

    This opportunity, offered by the National Institute on Deafness and Other Communication Disorders (NIDCD) at NIH, funds translational research projects that move published basic research findings into clinical practice, specifically targeting communication disorders (hearing, balance, smell, taste, voice, speech, and language). The program is designed to foster collaboration between basic scientists and clinicians, with the goal of developing new diagnostic, therapeutic, or preventive tools that have a clear and practical clinical impact.

    Projects must be milestone-driven and demonstrate a direct connection between the basic research findings and the targeted clinical condition. Early engagement with end users (e.g., clinicians, patients) is expected. The program is not intended for basic discovery, proof-of-concept, or high-risk clinical trials, nor for the extension of ongoing clinical studies or optimization of existing protocols without new basic discoveries.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.